In order for providers to achieve balance between patients who want more direction and patients who want more autonomy, the healthcare industry must first find some measure of patient engagement, said Julia Adler-Milstein, PhD, assistant professor at the School of Information and the School of Public Health at the University of Michigan.
In order for providers to achieve balance between patients who want more direction and patients who want more autonomy, the healthcare industry must first find some measure of patient engagement, said Julia Adler-Milstein, PhD, assistant professor at the School of Information and the School of Public Health at the University of Michigan.
Transcript (modified)
How do providers reconcile between patients who want to be told what to do and patients who want more of a say in their care?
The first thing we need to do is really figure out how do we measure patient engagement. And those measures, I think, need to be subjective because people are going to have different definitions of what it means for them to be engaged.
But right now we haven’t even had the ability to measure that well, and so we don’t know where we stand today. A lot of healthcare systems will say “I’m doing patient engagement” and then you ask them what they’re doing and they say, “Oh, you know, I have a portal where a patient can look up their lab results." And, again, maybe for some patients that feels like they are engaged, but for other patients that probably is going to really fall short of how they want to be engaged.
But until we measure it, it’s going to be very hard to know how we’re doing, and it’s going to be very hard to ultimately tie incentives to it. I think this is going to be the really transformative piece of this, when healthcare delivery systems feel like they have to prioritize patient engagement if they want to be competitive and effective; but I think patient engagement has just not reached that level of prioritization to date.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More